Andreas Schmidt

Andreas Schmidt is a seasoned entrepreneur and venture capital investor specializing in biotech and health innovation, currently leading the Springboard Health Ventures Fund. They serve on various boards, including BigOmics Analytics and Phinomics, while also holding significant roles at Singleron Biotechnologies and aescuvest. With a rich background as the former CEO of AYOXXA Biosystems GmbH, they played a pivotal role in commercializing advanced biotechnological solutions. Additionally, Andreas has contributed as a scholar, mentor, and expert across numerous organizations, reflecting a commitment to fostering innovation in the life sciences sector.